TY - JOUR
T1 - Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion
AU - Rodríguez-Lara, Simón Quetzalcoatl
AU - Cardona-Munõz, Ernesto German
AU - Ramírez-Lizardo, Ernesto Javier
AU - Totsuka-Sutto, Sylvia Elena
AU - Castillo-Romero, Araceli
AU - Garciá-Cobián, Teresa Arcelia
AU - Garciá-Benavides, Leonel
N1 - Publisher Copyright:
© 2016 Simón Quetzalcoatl Rodríguez-Lara et al.
PY - 2016
Y1 - 2016
N2 - Ischemia/reperfusion (I/R) lesions are a phenomenon that occurs in multiple pathological states and results in a series of events that end in irreparable damage that severely affects the recovery and health of patients. The principal therapeutic approaches include preconditioning, postconditioning, and remote ischemic preconditioning, which when used separately do not have a great impact on patient mortality or prognosis. Oxidative stress is known to contribute to the damage caused by I/R; however, there are no pharmacological approaches to limit or prevent this. Here, we explain the relationship between I/R and the oxidative stress process and describe some pharmacological options that may target oxidative stress-states.
AB - Ischemia/reperfusion (I/R) lesions are a phenomenon that occurs in multiple pathological states and results in a series of events that end in irreparable damage that severely affects the recovery and health of patients. The principal therapeutic approaches include preconditioning, postconditioning, and remote ischemic preconditioning, which when used separately do not have a great impact on patient mortality or prognosis. Oxidative stress is known to contribute to the damage caused by I/R; however, there are no pharmacological approaches to limit or prevent this. Here, we explain the relationship between I/R and the oxidative stress process and describe some pharmacological options that may target oxidative stress-states.
UR - http://www.scopus.com/inward/record.url?scp=85009451918&partnerID=8YFLogxK
U2 - 10.1155/2016/7190943
DO - 10.1155/2016/7190943
M3 - Artículo de revisión
C2 - 28116037
AN - SCOPUS:85009451918
SN - 1942-0900
VL - 2016
JO - Oxidative Medicine and Cellular Longevity
JF - Oxidative Medicine and Cellular Longevity
M1 - 7190943
ER -